Cargando…
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a profound impact on the world’s health and economy. Although the end of the pandemic may come in 2023, it is generally believed that the virus will not be completely eradic...
Autores principales: | England, Corbin, TrejoMartinez, Jonathan, PerezSanchez, Paula, Karki, Uddhab, Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054913/ https://www.ncbi.nlm.nih.gov/pubmed/36983772 http://dx.doi.org/10.3390/life13030617 |
Ejemplares similares
-
Cellular engineering of plant cells for improved therapeutic protein production
por: Karki, Uddhab, et al.
Publicado: (2021) -
Streptomyces: The biofactory of secondary metabolites
por: Alam, Khorshed, et al.
Publicado: (2022) -
Plant-Derived Cell-Free Biofactories for the Production of Secondary Metabolites
por: Buntru, Matthias, et al.
Publicado: (2022) -
Microalgal Cell Biofactory—Therapeutic, Nutraceutical and Functional Food Applications
por: Kiran, Boda Ravi, et al.
Publicado: (2021) -
Rhodococcus as Biofactories for Microbial Oil Production
por: Alvarez, Héctor M., et al.
Publicado: (2021)